Back to search

Trio Medicines Limited

05616306

active
Private Limited Company
Companies House
Health Score
65 / 100

Some Concerns

25/30
Filing
0/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

PAVILION VIEW, 19 NEW ROAD, EAST SUSSEX, BN1 1EY
Incorporated 08/11/2005

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

86900
Other human health activities

Officers

Dr Malcolm James Boyce

director · Since 08/11/2005

DOCTOR

BRITISH · UNITED KINGDOM · Age 86

Also on 5 other boards

Dr Steven John Warrington

director · Since 08/11/2005

DOCTOR

BRITISH · ENGLAND · Age 78

Persons with Significant Control

Dr Malcolm James Boyce

75–100% shares
75–100% votes

British · United Kingdom · Age 86

143 Holland Road, London, W14 8AS

Notified 17/11/2025

Former PSCs

Hammersmith Medicines Research Limited

Ceased 17/11/2025

CompanyRankvs 22440+ SIC 86900 peers
49

Financial strength100th percentile among SIC peers · 25/25
Employees12th percentile among SIC peers · 2/15
LiquidityCurrent ratio 0.06× · 2/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Henry Smith And Hamylton (Opticians) Limited
90
2Moorhouse Opticians Limited
90
3F I Maguire Limited
90
4G Hill Limited
90
5Dipple & Conway (Norwich) Limited
90
6Hogarth Health Club Limited(The)
90
7Auckland (Opticians) Limited
90
8National Unplanned Pregnancy Advisory Service Limited
90
9Gastank Limited
90
10Heritage Manor Limited
90
22440Trio Medicines Limited
59
How is this score calculated?
Financial strength25/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees2/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

of the parent company not yet having been completed, and the intercompany balance not yet having been written off, a material uncertainty exists regarding the company's ability to continue as a going concern. The directors expect the sale to go ahead, the intercompany balance to be written off, and for ongoing financial support to be provided from Hammersmith Medicines Research Limited to ena

Key FinancialsYear ending 31/01/2024

Net Worth

£14.8M

Balance sheet strength

Cash

£21k

Cash in the bank

Net Current Assets

-£2.0M

Working capital

Current Assets

£123k

Current Liabilities

£2.1M

Debtors

£102k

0avg. employees

Balance Sheet

Assets less current liabilities-£2.0M
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20240.06+£0
20230.21+£0
20221.75—

Derived from filed accounts. Not audited figures.